Search

everythinglearnresearchcommunity

for

Search:↓

Oral tranexamic acid is a safe and effective treatment for melasma.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

High testosterone increases heart disease risk in women with PCOS.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

A girl with lupus and trisomy X has a higher risk of bone problems like avascular necrosis and osteoporosis.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Biologics for severe asthma have known side effects, but some new risks need more study.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Substance abuse can cause various skin problems, including marks from injections, sores, premature aging, and increased cancer risk.